Active bone marrow S-values for the low-energy electron emitter terbium-161 compared to S-values for lutetium-177 and yttrium-90

BACKGROUND: Based on theoretical and preclinical results, terbium-161 may be a valid alternative to lutetium-177 and yttrium-90 in radionuclide therapies. The large low-energy electron emission from terbium-161 is a favorable feature in the treatment of disseminated disease, but its impact on the ra...

Descripción completa

Detalles Bibliográficos
Autores principales: Hemmingsson, Jens, Svensson, Johanna, van der Meulen, Nicholas P., Müller, Cristina, Bernhardt, Peter
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9509518/
https://www.ncbi.nlm.nih.gov/pubmed/36153386
http://dx.doi.org/10.1186/s40658-022-00495-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9509518/
https://www.ncbi.nlm.nih.gov/pubmed/36153386
http://dx.doi.org/10.1186/s40658-022-00495-7

Ejemplares similares